Leblanc, K.; Edwards, S.J.; Dranitsaris, G.; Leong, D.P.; Carrier, M.; Malone, S.; Rendon, R.A.; Bond, A.M.; Sitland, T.D.; Zalewski, P.;
et al. Drug Interactions between Androgen Receptor Axis-Targeted Therapies and Antithrombotic Therapies in Prostate Cancer: Delphi Consensus. Cancers 2024, 16, 3336.
https://doi.org/10.3390/cancers16193336
AMA Style
Leblanc K, Edwards SJ, Dranitsaris G, Leong DP, Carrier M, Malone S, Rendon RA, Bond AM, Sitland TD, Zalewski P,
et al. Drug Interactions between Androgen Receptor Axis-Targeted Therapies and Antithrombotic Therapies in Prostate Cancer: Delphi Consensus. Cancers. 2024; 16(19):3336.
https://doi.org/10.3390/cancers16193336
Chicago/Turabian Style
Leblanc, Kori, Scott J. Edwards, George Dranitsaris, Darryl P. Leong, Marc Carrier, Shawn Malone, Ricardo A. Rendon, Alison M. Bond, Troy D. Sitland, Pawel Zalewski,
and et al. 2024. "Drug Interactions between Androgen Receptor Axis-Targeted Therapies and Antithrombotic Therapies in Prostate Cancer: Delphi Consensus" Cancers 16, no. 19: 3336.
https://doi.org/10.3390/cancers16193336
APA Style
Leblanc, K., Edwards, S. J., Dranitsaris, G., Leong, D. P., Carrier, M., Malone, S., Rendon, R. A., Bond, A. M., Sitland, T. D., Zalewski, P., Wang, M., & Emmenegger, U.
(2024). Drug Interactions between Androgen Receptor Axis-Targeted Therapies and Antithrombotic Therapies in Prostate Cancer: Delphi Consensus. Cancers, 16(19), 3336.
https://doi.org/10.3390/cancers16193336